Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT DAXOR CORPORATION

Daxor Corporation (NASDAQ: DXR)
Listen to this Section


$9.95
-1.1400 ( -10.30% ) 0.0K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open $9.95
Previous Close $11.09
Volume 0.0K
Market Cap $62.53M
Day Range $10.80 - $10.80
52 Week Range $8.29 - $14.76
Shares Outstanding 5.83M
Change % -10.30%
Net Change ▼ -1.1400
Insider Ownership 0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year1983
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 53,324.00

Date Type Amount Purchased Purchaser
2025-11-14 Buy 2344.00 Jefferies John
2025-04-07 Buy 2063.00 Feldschuh Michael Richard
2024-12-10 Buy 45000.00 Feldschuh Michael Richard
2024-12-10 Buy 32000.00 Feldschuh Jonathan Adam
2024-12-10 Buy 4750.00 Michel Robert J
2024-07-17 Sale -2500.00 Cremisi Henry D.
2024-07-17 Sale -2500.00 DesRosiers Caleb
2024-07-17 Sale -2500.00 Goudie Joy S.
2024-07-17 Sale -2500.00 Feuer Edward
2024-03-27 Buy 750.00 Michel Robert J

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Jul 01, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
def Proxies and info statements 3 Jun 06, 2025

Latest News


× Before browsing our site, please accept our cookies policy